Sentences with phrase «emory vaccine»

The research team, led by Emory Vaccine Center immunologist Bali Pulendran, discovered that mice lacking the amino acid sensor GCN2 are more sensitive to the chemical irritant DSS (dextran sodium sulfate), often used to model colitis in animals.

The first author is Will Hudson, PhD, previously a graduate student with Ortlund and now a postdoctoral fellow in Rafi Ahmed's lab at Emory Vaccine Center.

Silvestri's colleagues on this study include Maud Mavigner, PhD, Yerkes and Emory Vaccine Center, Ann Chahroudi, MD, PhD, Emory University School of Medicine (EUSOM) Department of Pediatrics, and Leslie Kean, MD, PhD, and Benjamin Watkins, MD, EUSOM Department of Surgery.

There are many variations of H1N1, says Rafi Ahmed, director of the Emory Vaccine Center and a Georgia Research Alliance Eminent Scholar, but this technology could be used to identify a very specific strain, such as the one weâ $ ™ re dealing with in the current pandemic.

David Garber and Mark Feinberg, respected HIV investigators at the Emory Vaccine Research Center in Atlanta, write:

The reports build on findings some years ago from Emory Vaccine Center researchers led by Rafi Ahmed.

He was also instrumental in recruiting Rafi Ahmed to establish and lead the Emory Vaccine Center.

Rama Rao Amara, a vaccine researcher at Emory Vaccine Center and Yerkes National Primate Research Center, and Harriet Robinson, former head of microbiology and immunology at Yerkes and now chief scientific officer at the firm GeoVax, both described extra ingredients for the DNA / MVA vaccine that Robinson designed while at Yerkes in collaboration with NIH researchers.

-- Rafi Ahmed's lab at Emory Vaccine Center.

-- Joshy Jacob's lab at Emory Vaccine Center.

Scientists from Emory Vaccine Center have now shown what molecular features distinguish the subset of T cells that wake up when re-energized by PD -1-blocking agents.

Anti-flu peptides could become handy when vaccines are unavailable, in the case of a new pandemic strain, or when circulating strains become resistant to current drugs, says senior author Joshy Jacob, PhD, associate professor of microbiology and immunology at Emory Vaccine Center and Emory University School of Medicine.

A component of the skin mucus secreted by South Indian frogs can kill the H1 variety of influenza viruses, researchers from Emory Vaccine Center and the Rajiv Gandhi Center for Biotechnology in India have discovered.

Related sites Bali Pulendran's laboratory Web site at the Emory Vaccine Center The Centers for Disease Control and Prevention's anthrax Web site

Ellebedy and Rafi Ahmed, PhD, director of Emory Vaccine Center, teamed up with Katherine Jackson, PhD and Scott Boyd, PhD at Stanford to analyze the DNA bar codes.

The lab of co-author Rafi Ahmed, director of Emory Vaccine Center, has reported analogous cells in mice with chronic viral infections.

The vaccines being developed in laboratories around the world «offer more promise than we've ever had,» says Walter Orenstein, associate director of the Emory Vaccine Center in Atlanta.

Research by Saad Omer, an epidemiologist at the Emory Vaccine Center in Atlanta, Georgia, points out similar abuses: he and his colleagues have found that medical exemptions are up to six times more common in states that have lax medical - exemption requirements or don't allow philosophical exemptions.

Scientists led by Hunter at Emory Vaccine Center / Center for AIDS Research teamed up with lead author Jonathan Carlson, PhD, and colleagues at Microsoft Research.

«The best explanation for what we are seeing is that frequently, after exposure to HIV, a few cells in the genital tract are infected, without establishment of a systemic infection,» says senior investigator Eric Hunter, PhD, professor of pathology and laboratory medicine at Emory University School of Medicine, Emory Vaccine Center, and Yerkes National Primate Research Center.

Not exact matches

Offit, Edwards and Saad Omer, an associate professor at Emory University's Vaccine Center, concur.

The new technique, pioneered by Wilson and fellow researchers at the Emory University School of Medicine in Atlanta, saves time by using antibodies produced by so - called B cells (white blood cells that produce and then ferry them to infection sites to battle invading germs) in response to vaccines instead of to actual infections.

«You certainly can't do a $ 100 million study for every candidate vaccine that appears safe and immunogenic,» says Mark Mulligan, a molecular virologist who heads the vaccine center at Emory University in Atlanta and does human challenges with norovirus and tuberculosis.

Public health policy and research must overcome several barriers to developing vaccines for pregnant women, say authors Saad B. Omer, MBBS, PhD, professor of global health, epidemiology and pediatrics at Emory University and Richard H. Beigi, MD, MSc, associate professor of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh Medical Center and chief medical officer at Magee - Womens Hospital of UPMC.

Two presentations on Emory research at last week's AIDS Vaccine 2010 conference concerned adjuvants.

As one of six GRA universities, Emory has benefited from this unique partnership in numerous ways: through its 11 Eminent Scholars, multidisciplinary university and industry collaborations, and support for research in vaccines, nanomedicine, transplantation, neurosciences, pediatrics, biomedical engineering, clinical research, and drug discovery.

At Emory, Compans has led research on ways to improve influenza vaccination, such as vaccines based on non-infectious virus - like particles and microneedle patches for delivery (now being tested clinically).

Some of the pediatric research conducted in a new building to be built on the Emory campus will focus on cardiology, cancer, vaccines, and new drug discovery.

Working with Inovio Pharmaceuticals, Duke University, Emory University, University of Massachusetts and the National Institutes of Health, the group aims to build on the success of previous generations of DNA vaccines in order to induce strong cellular and humoral responses.

By nominating Miller for the award and matching GRA's investment, Emory raises its profile as a leader in emerging technologies in vaccines and therapeutics.